121 related articles for article (PubMed ID: 410340)
1. [An acellular vaccine from Pseudomonas aeruginosa. II. -- Estimate of immuneserum protective effect by measure of bacterial clearance (author's transl)].
Daoulas-Le Bourdelles F; Berche P; Véron M
Ann Microbiol (Paris); 1977 Jul; 128B(1):61-71. PubMed ID: 410340
[TBL] [Abstract][Full Text] [Related]
2. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
[TBL] [Abstract][Full Text] [Related]
3. [An acellular vaccine from "Pseudomonas aeruginosa." I. Preparation and activity (author's transl)].
Berche P; Véron M; Tinelli R
Ann Microbiol (Paris); 1976; 127A(2):247-59. PubMed ID: 822769
[TBL] [Abstract][Full Text] [Related]
4. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
5. A new polyvalent pseudomonas vaccine.
Merle P; Robbel L; Hungerer KD
Behring Inst Mitt; 1984 Nov; (76):113-20. PubMed ID: 6441560
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.
Frank DW; Vallis A; Wiener-Kronish JP; Roy-Burman A; Spack EG; Mullaney BP; Megdoud M; Marks JD; Fritz R; Sawa T
J Infect Dis; 2002 Jul; 186(1):64-73. PubMed ID: 12089663
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa. II. Experimental acellular vaccine of an endotoxin and anatoxin type.
Bĕlohlávek S; Pavlík V; Rencová J; Stránský V; Nováková L; Sourek J; Výmola F
J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):343-52. PubMed ID: 3119704
[TBL] [Abstract][Full Text] [Related]
8. Mouse-protection experience with monovalent Pseudomonas aeruginosa vaccine.
Sourek J; Výmola F; Zelenková L
Zentralbl Bakteriol A; 1980 Mar; 246(3):353-62. PubMed ID: 6775443
[TBL] [Abstract][Full Text] [Related]
9. Protective characteristics of the antigen common to Pseudomonas and Vibrio and significance of bacterial endotoxins in protection against selected bacterial infections.
Sourek J
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):538-47. PubMed ID: 2413656
[TBL] [Abstract][Full Text] [Related]
10. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
[TBL] [Abstract][Full Text] [Related]
11. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa].
Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W
Pol Tyg Lek; 1980 Jul; 35(27):1013-5. PubMed ID: 6775310
[No Abstract] [Full Text] [Related]
12. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
[TBL] [Abstract][Full Text] [Related]
13. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
von Specht BU; Domdey H; Schödel F; Blum B; Lücking C; Knapp B; Muth G; Hungerer KD; Bröker M
Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
[TBL] [Abstract][Full Text] [Related]
14. Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells.
Worgall S; Kikuchi T; Singh R; Martushova K; Lande L; Crystal RG
Infect Immun; 2001 Jul; 69(7):4521-7. PubMed ID: 11401995
[TBL] [Abstract][Full Text] [Related]
15. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
[TBL] [Abstract][Full Text] [Related]
16. Determination of type specific IgG Pseudomonas antibodies by the ELISA test after administration of the anti Pseudomonas aeruginosa vaccine.
Meitert T; Meitert E; Pencu E; Tonciu M
Arch Roum Pathol Exp Microbiol; 1984; 43(1):53-60. PubMed ID: 6442132
[No Abstract] [Full Text] [Related]
17. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
18. Protection against hemorrhagic pneumonia of mink by Pseudomonas aeruginosa multicomponent vaccine.
Aoi Y; Noda H; Yanagawa R; Homma JY; Abe C; Morihara K; Goda A; Takeuchi S; Ishihara T
Jpn J Exp Med; 1979 Jun; 49(3):199-207. PubMed ID: 114699
[TBL] [Abstract][Full Text] [Related]
19. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization.
Lange KH; Hougen HP; Høiby N; Fomsgaard A; Rygaard J; Johansen HK
APMIS; 1995 May; 103(5):367-74. PubMed ID: 7654361
[TBL] [Abstract][Full Text] [Related]
20. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
